Concise health risk tracking scale

A brief self-report and clinician rating of suicidal risk

Madhukar H. Trivedi, Stephen R. Wisniewski, David W. Morris, Maurizio Fava, Jackie K. Gollan, Diane Warden, Andrew A. Nierenberg, Bradley N. Gaynes, Mustafa M. Husain, James F. Luther, Sidney Zisook, A. John Rush

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Method: Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health - funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. Results: The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. Conclusions: The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. Trial Registration: clincaltrials.gov Identifier: NCT00532103.

Original languageEnglish (US)
Pages (from-to)757-764
Number of pages8
JournalJournal of Clinical Psychiatry
Volume72
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Self Report
Health
Major Depressive Disorder
Psychometrics
Suicidal Ideation
Suicide
Psychiatry
National Institute of Mental Health (U.S.)
Psychomotor Agitation
Guilt
Serotonin Uptake Inhibitors
Appetite
Checklist
Diagnostic and Statistical Manual of Mental Disorders
Social Support
Antidepressive Agents
Fatigue
Primary Health Care
Sleep
Emotions

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Concise health risk tracking scale : A brief self-report and clinician rating of suicidal risk. / Trivedi, Madhukar H.; Wisniewski, Stephen R.; Morris, David W.; Fava, Maurizio; Gollan, Jackie K.; Warden, Diane; Nierenberg, Andrew A.; Gaynes, Bradley N.; Husain, Mustafa M.; Luther, James F.; Zisook, Sidney; Rush, A. John.

In: Journal of Clinical Psychiatry, Vol. 72, No. 6, 06.2011, p. 757-764.

Research output: Contribution to journalArticle

Trivedi, MH, Wisniewski, SR, Morris, DW, Fava, M, Gollan, JK, Warden, D, Nierenberg, AA, Gaynes, BN, Husain, MM, Luther, JF, Zisook, S & Rush, AJ 2011, 'Concise health risk tracking scale: A brief self-report and clinician rating of suicidal risk', Journal of Clinical Psychiatry, vol. 72, no. 6, pp. 757-764. https://doi.org/10.4088/JCP.11m06837
Trivedi, Madhukar H. ; Wisniewski, Stephen R. ; Morris, David W. ; Fava, Maurizio ; Gollan, Jackie K. ; Warden, Diane ; Nierenberg, Andrew A. ; Gaynes, Bradley N. ; Husain, Mustafa M. ; Luther, James F. ; Zisook, Sidney ; Rush, A. John. / Concise health risk tracking scale : A brief self-report and clinician rating of suicidal risk. In: Journal of Clinical Psychiatry. 2011 ; Vol. 72, No. 6. pp. 757-764.
@article{7d0157e516a24f5c92c1084453af5250,
title = "Concise health risk tracking scale: A brief self-report and clinician rating of suicidal risk",
abstract = "Objective: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Method: Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health - funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. Results: The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. Conclusions: The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. Trial Registration: clincaltrials.gov Identifier: NCT00532103.",
author = "Trivedi, {Madhukar H.} and Wisniewski, {Stephen R.} and Morris, {David W.} and Maurizio Fava and Gollan, {Jackie K.} and Diane Warden and Nierenberg, {Andrew A.} and Gaynes, {Bradley N.} and Husain, {Mustafa M.} and Luther, {James F.} and Sidney Zisook and Rush, {A. John}",
year = "2011",
month = "6",
doi = "10.4088/JCP.11m06837",
language = "English (US)",
volume = "72",
pages = "757--764",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "6",

}

TY - JOUR

T1 - Concise health risk tracking scale

T2 - A brief self-report and clinician rating of suicidal risk

AU - Trivedi, Madhukar H.

AU - Wisniewski, Stephen R.

AU - Morris, David W.

AU - Fava, Maurizio

AU - Gollan, Jackie K.

AU - Warden, Diane

AU - Nierenberg, Andrew A.

AU - Gaynes, Bradley N.

AU - Husain, Mustafa M.

AU - Luther, James F.

AU - Zisook, Sidney

AU - Rush, A. John

PY - 2011/6

Y1 - 2011/6

N2 - Objective: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Method: Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health - funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. Results: The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. Conclusions: The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. Trial Registration: clincaltrials.gov Identifier: NCT00532103.

AB - Objective: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Method: Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health - funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. Results: The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. Conclusions: The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. Trial Registration: clincaltrials.gov Identifier: NCT00532103.

UR - http://www.scopus.com/inward/record.url?scp=79959580519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959580519&partnerID=8YFLogxK

U2 - 10.4088/JCP.11m06837

DO - 10.4088/JCP.11m06837

M3 - Article

VL - 72

SP - 757

EP - 764

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 6

ER -